Thus, although LKB1 loss and its effects on metabolic dysregulation in cancer have been thoroughly investigated, it is increasingly clear that LKB1 loss also has significant consequences related to immune dysfunction and the tumor microenvironment. The gene discussed is STK11; the disease is cancer.